Neuraxpharm establishes presence in Switzerland with acquisition of leading CBD company, S.T.U. GmbH, owner of market leading brand HemplixTM
Neuraxpharm Group (Neuraxpharm), a leading European specialty pharmaceutical company focused on the central nervous system (CNS), today provides a business update for the last twelve months.
New collaboration between Neuraxpharm and Bened Biomedical expands portfolio of Consumer Healthcare products
